Explore Cathepsin F/CTSF gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
Cathepsins are papain family cysteine proteinases that represent a major component of the lysosomal proteolytic system. Cathepsins generally contain a signal sequence, followed by a propeptide and then a catalytically active mature region. The very long (251 amino acid residues) proregion of the cathepsin F precursor contains a C-terminal domain similar to the pro-segment of cathepsin L-like enzymes, a 50-residue flexible linker peptide, and an N-terminal domain predicted to adopt a cystatin-like fold. The cathepsin F proregion is unique within the papain family cysteine proteases in that it contains this additional N-terminal segment predicted to share structural similarities with cysteine protease inhibitors of the cystatin superfamily. This cystatin-like domain contains some of the elements known to be important for inhibitory activity. CTSF encodes a predicted protein of 484 amino acids which contains a 19 residue signal peptide. Cathepsin F contains five potential N-glycosylation sites, and it may be targeted to the endosomal/lysosomal compartment via the mannose 6-phosphate receptor pathway. The cathepsin F gene is ubiquitously expressed, and it maps to chromosome 11q13, close to the gene encoding cathepsin W. [provided by RefSeq, Jul 2008]
Target ID |
GM-T77236
|
Target Name |
Cathepsin F/CTSF
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
8722
|
Gene ID |
100058569 (Equus caballus), 101099835 (Felis catus), 361704 (Rattus norvegicus), 476010 (Canis lupus familiaris) 509715 (Bos taurus), 56464 (Mus musculus), 713743 (Macaca mulatta), 8722 (Homo sapiens)
|
Target Alternative Names |
CTSF,Ctsf,CATSF,CLN13
|
Uniprot Accession |
Q9R013,Q9UBX1
|
Uniprot Entry Name |
|
Protein Sub-location |
Transmembrane Protein
|
Category |
Therapeutics Target
|
Disease |
|
Disease from KEGG |
Lysosome, Apoptosis
|
Gene Ensembl |
ENSECAG00000022139, ENSCAFG00845012685, ENSBTAG00000010994, ENSMUSG00000083282, ENSMMUG00000002496, ENSG00000174080
|
Target Classification |
|
Pre-made viral vector of Cathepsin F/CTSF cDNA Clones/ORF Plasmid
Cathepsin F/CTSF siRNA/miRNA/oligo for RNA interfence (RNAi)
Cat No. | Product Name | GeneID | Species | Grade | Detail |
---|
pGMoligo8722 | Pre-made Human CTSF/CATSF/CLN13 siRNA oligo Duplex | 8722 | Human | In-vitro grade; in-vivo grade | Detail |
pGMoligo361704 | Pre-made Rat Ctsf siRNA oligo Duplex | 361704 | Rat | In-vitro grade; in-vivo grade | Detail |
pGMoligo56464 | Pre-made Mouse Ctsf siRNA oligo Duplex | 56464 | Mouse | In-vitro grade; in-vivo grade | Detail |
pGMoligo713743 | Pre-made Cynomolgus/Rhesus macaque CTSF siRNA oligo Duplex | 713743 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
pGMoligo101099835 | Pre-made Cat/Feline CTSF siRNA oligo Duplex | 101099835 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
pGMoligo476010 | Pre-made Dog/Canine CTSF siRNA oligo Duplex | 476010 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
pGMoligo509715 | Pre-made Bovines/Cattle CTSF siRNA oligo Duplex | 509715 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
pGMoligo100058569 | Pre-made Equine/Horse CTSF siRNA oligo Duplex | 100058569 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
Cathepsin F/CTSF antibody/GMab
Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
---|
GM-Tg-hg-T77236-Ab | Human | Anti-Human Cathepsin F/CTSF monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-rg-T77236-Ab | Rat | Anti-Rat Cathepsin F/CTSF monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-mg-T77236-Ab | Mouse | Anti-Mouse Cathepsin F/CTSF monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-cynog-T77236-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque Cathepsin F/CTSF monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-felg-T77236-Ab | Cat/Feline | Anti-Cat/Feline Cathepsin F/CTSF monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-cang-T77236-Ab | Dog/Canine | Anti-Dog/Canine Cathepsin F/CTSF monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-bovg-T77236-Ab | Bovines/Cattle | Anti-Bovines/Cattle Cathepsin F/CTSF monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
GM-Tg-equg-T77236-Ab | Equine/Horse | Anti-Equine/Horse Cathepsin F/CTSF monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
Cathepsin F/CTSF VLP (virus-like particle)
Cat No. | Species | Antigen Name | Expression Platform | Detail |
---|
GM-Tg-hg-T77236-Ag | Human | Human Cathepsin F/CTSF VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-rg-T77236-Ag | Rat | Rat Cathepsin F/CTSF VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-mg-T77236-Ag | Mouse | Mouse Cathepsin F/CTSF VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-cynog-T77236-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque Cathepsin F/CTSF VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-felg-T77236-Ag | Cat/Feline | Cat/Feline Cathepsin F/CTSF VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-cang-T77236-Ag | Dog/Canine | Dog/Canine Cathepsin F/CTSF VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-bovg-T77236-Ag | Bovines/Cattle | Bovines/Cattle Cathepsin F/CTSF VLP (virus-like particle) | HEK293 | Products Developing |
GM-Tg-equg-T77236-Ag | Equine/Horse | Equine/Horse Cathepsin F/CTSF VLP (virus-like particle) | HEK293 | Products Developing |